TS
Tejas Shah
About Tejas Shah
Data last updated:
Tejas Shah has 17 years in corporate governance. Holds Director and Nominee Director roles. Currently with 3 companies, including Accumax Lab Devices Private Limited and Neuation Technologies Private Limited. Formerly with 5 companies, such as Genefact Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹283 Cr; the largest is Accumax Lab Devices Private Limited at ₹256 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Accumax Lab Devices Private Limited U33110GJ2009PTC056957 | Director | 15 May 2009 | 2009 | ₹256 Cr (FY 2025) | Active |
 Sterilem Private Limited U46596GJ2025PTC157677 | Nominee Director | 06 Jan 2025 | 2025 | ₹26.18 Cr (FY 2026) | Active |
 Anahat Solutions Private Limited U72900GJ2021PTC127007 | Director | 02 Nov 2021 | 2021 | ₹3.1 Lakh (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Genefact Private Limited U24290GJ2022PTC136995 | Director | 25 Nov 2022 | 2022 | – | Amalgamated |
 Neuation Technologies Private Limited U33125GJ2010PTC063144 | Director | 04 Dec 2010 | 2010 | ₹29.24 Cr (FY 2021) | Amalgamated |
| Accumax Lab Devices Private Limited U33125GJ2017PTC099233 | Director | 26 Sep 2017 | 2017 | – | Amalgamated |
 Fine Care Corporation Private Limited U33300GJ2017PTC098910 | Director | 31 Aug 2017 | 2017 | – | Amalgamated |
| Firstcare Biosystem Private Limited U33309GJ2017PTC099229 | Director | 25 Sep 2017 | 2017 | – | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tejas Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tejas Shah
Tejas Shah has 17 years in corporate governance. Holds Director and Nominee Director roles. Currently with 3 companies, including Accumax Lab Devices Private Limited and Neuation Technologies Private Limited. Formerly with 5 companies, such as Genefact Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹283 Cr; the largest is Accumax Lab Devices Private Limited at ₹256 Cr (FY 2025).
Tejas Shah is associated with 3 companies as Director and Nominee Director, including Accumax Lab Devices Private Limited (₹256 Cr), Sterilem Private Limited (₹26.18 Cr), Anahat Solutions Private Limited (₹3.1 Lakh).
Tejas Shah has expertise in General Business, Technology.
Tejas Shah has 17 years in corporate governance.
By reported revenue, the largest current company of Tejas Shah is Accumax Lab Devices Private Limited, with revenue of ₹256 Cr (FY 2025).
The 3 current companies of Tejas Shah that report revenue have a combined latest revenue of ₹283 Cr.
Tejas Shah currently holds positions at 3 companies: Accumax Lab Devices Private Limited (₹256 Cr), Sterilem Private Limited (₹26.18 Cr), Anahat Solutions Private Limited (₹3.1 Lakh).